InMed Pharmaceuticals (INM) Research & Development (2019 - 2026)
InMed Pharmaceuticals (INM) posted quarterly Research & Development of $1.0 million for Q1 2026, up 140.41% year-over-year from $425370.0 in Q1 2025, and up 62.16% quarter-over-quarter from $630636.0 in Q4 2025.
InMed Pharmaceuticals (INM) Research & Development (2019 - 2026) Analysis & Trends
InMed Pharmaceuticals' Research & Development history runs 8 years deep, the most recent figure standing at $1.0 million for Q1 2026.
- In Q1 2026, Research & Development rose 140.41% year-over-year to $1.0 million; the TTM figure through Mar 2026 stood at $2.8 million (up 6.17% YoY), while the FY2025 annual figure was $2.9 million, down 11.3% from the prior year.
- Research & Development for Q1 2026 stood at $1.0 million, up from $630636.0 in the prior quarter.
- The five-year high for Research & Development was $3.6 million in Q2 2023, with the low at $21915.0 in Q1 2023.
- The 5-year median for Research & Development is $658869.0 (2024), against an average of $964497.1.
- The sharpest annual moves came in 2022 and 2024: Research & Development sank 98.95% in 2022, then soared 2896.87% in 2024.
- InMed Pharmaceuticals' Research & Development stood at $26596.0 in 2022, then jumped by 2192.79% to $609791.0 in 2023, then surged by 46.8% to $895176.0 in 2024, then declined by 29.55% to $630636.0 in 2025, then soared by 62.16% to $1.0 million in 2026.
- Business Quant data shows INM's Research & Development at $1.0 million in Q1 2026, $630636.0 in Q4 2025, and $581612.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn | 970.00 Mn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn | -1.05 Bn |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn | 146.30 Mn |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn | 248.30 Mn |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn | 326.70 Mn |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn | 92.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | InMed Pharmaceuticals | 6.56 Mn | 1.32 Mn | - | 1.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.02 Mn |
| Dec 31, 2025 | 630,636.00 |
| Sep 30, 2025 | 581,612.00 |
| Jun 30, 2025 | 609,972.00 |
| Mar 31, 2025 | 425,370.00 |
| Dec 31, 2024 | 895,176.00 |
| Sep 30, 2024 | 700,145.00 |
| Jun 30, 2024 | 658,869.00 |
| Mar 31, 2024 | 656,764.00 |
| Dec 31, 2023 | 609,791.00 |
| Sep 30, 2023 | 1.29 Mn |
| Jun 30, 2023 | 3.63 Mn |
| Mar 31, 2023 | 21,915.00 |
| Dec 31, 2022 | 26,596.00 |
| Sep 30, 2022 | 1.38 Mn |
| Jun 30, 2022 | 1.50 Mn |
| Mar 31, 2022 | 1.75 Mn |
| Dec 31, 2021 | 2.54 Mn |
| Sep 30, 2021 | 1.49 Mn |
| Jun 30, 2021 | 1.72 Mn |